Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenues:
Premiums	$ 24,657	$ 21,003	$ 74,117	$ 63,894
Net investment income	277	201	885	515
Total revenues	89,764	81,159	263,963	238,621
Operating costs:
Cost of products sold	54,688	50,365	159,679	145,164
Health care costs	21,499	17,401	63,729	52,814
Restructuring charges	11	0	507	0
Opioid litigation charges	0	5,220	0	5,704
Loss on assets held for sale	0	2,480	349	2,521
Operating expenses	9,876	9,612	29,329	28,123
Total operating costs	86,074	85,078	253,593	234,326
Operating income (loss)	3,690	(3,919)	10,370	4,295
Interest expense	693	566	1,968	1,735
Other income	(22)	(41)	(66)	(126)
Income (loss) before income tax provision (benefit)	3,019	(4,444)	8,468	2,686
Income tax provision (benefit)	754	(1,045)	2,147	691
Net income (loss)	2,265	(3,399)	6,321	1,995
Net income attributable to noncontrolling interests	(4)	(7)	(23)	(18)
Net income (loss) attributable to CVS Health	$ 2,261	$ (3,406)	$ 6,298	$ 1,977
Net income (loss) per share attributable to CVS Health:
Basic (in dollars per share)	$ 1.76	$ (2.59)	$ 4.90	$ 1.51
Diluted (in dollars per share)	$ 1.75	$ (2.59)	$ 4.88	$ 1.49
Weighted average shares outstanding:
Basic (in shares)	1,287	1,315	1,284	1,313
Diluted (in shares)	1,290	1,315	1,289	1,324
Dividends declared per share (in dollars per share)	$ 0.605	$ 0.55	$ 1.815	$ 1.65
Cost, Product and Service [Extensible List]	Products	Products	Products	Products
Products
Revenues:
Revenues	$ 61,298	$ 57,643	$ 179,984	$ 166,959
Services
Revenues:
Revenues	$ 3,532	$ 2,312	$ 8,977	$ 7,253